Institut Català d'Oncologia

Barcelona 8916

1 studies enrolling now · 9 studies all time

What they study most

Advanced Malignancies, Carcinoma, Cervical Carcinoma, Colorectal Cancer Metastatic, Early Breast Cancer, Metastatic Colorectal Cancer, Metastatic Melanoma, Metastatic Solid Tumor, Non Hodgkin Lymphoma, Triple Negative Breast Cancer

Studies at this site

• Study of PM54 in Combination With Immunotherapy in Adult Participants With Advanced Malignancies — Recruiting now
• Study of LN-145, Autologous Tumor Infiltrating Lymphocytes in the Treatment of Patients With Cervical Carcinoma — Stopped early
• Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors — Running, not enrolling
• Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma — Completed
• An Open-label, Dose Escalation Trial to Evaluate the Safety and Pharmacokinetics of HMPL-523 in Patients With Lymphoma — Stopped early
• A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer — Stopped early
• A Phase III Study of Xilonix in Patients With Advanced Colorectal Cancer — Stopped early
• Sym004 Versus Futuximab or Modotuximab in Patients With mCRC — Stopped early
• A Comparison of Intra-operative Radiotherapy Boost With External Beam Radiotherapy Boost in Early Breast Cancer. — Status unconfirmed